Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Cango Inc. to Report Third Quarter 2024 Financial Results on November 4, 2024 Eastern Time 2024-10-31 20:00
Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology 2024-10-31 20:00
I-Mab to Release Q3 2024 Financial Results on November 14, 2024 2024-10-31 19:00
Recurrent Energy to deliver 1,800 MWh of energy storage and 150 MWac of solar capacity to Arizona Public Service by 2026 2024-10-31 19:00
Recurrent Energy Announces Successful Operation of 134 MW Solar Project 2024-10-31 19:00
China Yuchai Terminates Its Share Buyback Plan 2024-10-31 18:00
Hyundai Motor Unveils Next Step in its Hydrogen Legacy with new INITIUM FCEV Concept 2024-10-31 17:35
Achieved IDR 45.36 Trillion Profit in Q3 2024, BRI Strengthens Performance Fundamentals 2024-10-31 17:32
Ericsson targets high-performing programmable networks with new 5G Advanced software 2024-10-31 17:22
NetEase to Report Third Quarter 2024 Financial Results on November 14 2024-10-31 16:30
Youdao to Report Third Quarter 2024 Financial Results on November 14 2024-10-31 16:30
Full Truck Alliance Co. Ltd. to Announce Third Quarter 2024 Financial Results on Wednesday, November 20, 2024 2024-10-31 16:00
"Bleach: Brave Souls" Anime Broadcast Celebration Special: Thousand-Year Blood War Zenith Summons: Puppets Begins with Thousand-Year Blood War 2024 Versions of Giselle & Others 2024-10-31 15:40
ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs) 2024-10-31 14:31
CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK 2024-10-31 13:00
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:34
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:02
EQT Acquires Leading SaaS Talent Solutions Provider PageUp to Accelerate Global Expansion and Product Innovation 2024-10-31 11:35
AIKO Showcases its High-Efficiency N-type ABC Modules at All Energy Australia 2024-10-31 10:44
Regal Hotels Pioneers Green Meetings Elevating Sustainable Practices for MICE Events in Hong Kong 2024-10-31 09:20
1 23 24 25 26 27 3395